An ongoing dialogue on HIV/AIDS, infectious diseases,
December 10th, 2008
Unintended Consequences of ART “Rollout”
According to this BBC article, teenagers in South Africa are grinding up antiretrovirals and then smoking them for their “hallucinogenic and relaxing effect”.
(Apologies for the pun on the title.)
It’s impossible to tell with a report like this how widespread the practice is, but it’s potentially worrisome. And no mention in the article which antivirals are being used, though of course one suspects efavirenz. I’ve heard rumors of a “street value” for efavirenz as a mind-altering drug, but not specifically of anyone smoking it.
Does anyone have more details on this?
(Thanks to H Heller for the link.)
Categories: Health Care, HIV, Infectious Diseases, Misc, Patient Care, Policy
Tags: antiretrovirals, clinical care, HIV, Infectious Diseases, Policy
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
Most Popular Posts
-
From the Blog — Most Recent Articles
- Dengue, Malaria, HIV Cure, and Others — First Cold Snap of the Winter ID Link-o-Rama December 10, 2025
- ID Things to Be Grateful for — 2025 Edition November 24, 2025
- When AI Gets the Medical Advice Wrong — and Right November 18, 2025
- Hot Takes from IDWeek: CDC, COVID, and Two Doses of Dalbavancin November 13, 2025
- Favorite ID Fellow Consults: Johns Hopkins Edition November 7, 2025
FROM NEJM — Recent Infectious Disease Articles- History of Medicine: Smallpox at the Siege of Boston, November 1775–March 1776 December 11, 2025Smallpox played a pivotal role throughout the American Revolution, but the record remains ambiguous about whether British officers weaponized refugees to sow pestilence in the Continental Army.
- Current and Emerging Approaches to Evaluating Influenza Vaccine Performance December 11, 2025Randomized, placebo-controlled trials are widely accepted as the scientific reference standard to determine a causal association between an intervention and an outcome. They are pivotal for product licensure. Although such trials establish safety and efficacy with the assumption that bias has been eliminated, limitations remain. For vaccines, establishing the duration...
- High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults December 11, 2025Among adults 65 years of age or older, a high-dose influenza vaccine did not result in a significantly lower incidence of hospitalization for influenza or pneumonia than a standard-dose vaccine.
- High-Dose Influenza Vaccine to Reduce Hospitalizations December 11, 2025In adults 65 to 79 years of age, there appeared to be fewer hospitalizations for influenza or pneumonia with high-dose influenza vaccine than with the standard dose, with a similar incidence of serious adverse events.
- Brief Report: Prime Editing for p47phox-Deficient Chronic Granulomatous Disease December 7, 2025In this study, gene editing with a prime editor was used to treat two persons with chronic granulomatous disease caused by a small deletion in the gene NCF1.
- History of Medicine: Smallpox at the Siege of Boston, November 1775–March 1776 December 11, 2025
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster
